PMID- 30709384
OWN - NLM
STAT- In-Process
LR  - 20190208
IS  - 1471-2407 (Electronic)
IS  - 1471-2407 (Linking)
VI  - 19
IP  - 1
DP  - 2019 Feb 1
TI  - Predictors for use of psychosocial services in patients with metastatic
      colorectal cancer receiving first line systemic treatment.
PG  - 115
LID - 10.1186/s12885-019-5318-9 [doi]
AB  - BACKGROUND: Patients with advanced disease experience high levels of
      psychological distress, yet there is low uptake of psychosocial services offered 
      to patients who screened positive for distress. In this study we aimed to
      identify predictors for use of psychosocial services in patients with metastatic 
      colorectal cancer (mCRC) receiving first line chemotherapy enrolled in a
      prospective cluster randomized trial (CRT). METHODS: Patients completed measures 
      on psychological distress, physical distress, and quality of life at baseline.
      Demographics, clinical characteristics at baseline and clinical events during
      treatment (e.g. severe adverse events, clinical benefit) were extracted from
      patient records. Patients reported psychosocial service utilization in- and
      outside the hospital after 10, 24 and 48 weeks of treatment. Multivariable
      logistic regression models were used to identify predictors for the use of
      psychosocial services. RESULTS: Out of 349 patients, seventy patients (20.0%)
      used psychosocial support services during the follow-up period. Use of
      psychosocial services was associated with younger age, a higher educational
      level, presence of more pain (at baseline), and the expressed need to talk to a
      professional (at baseline). In addition, patients without progressive disease
      within the first ten weeks of treatment were more likely to use psychosocial
      services . CONCLUSIONS: One in five patients with mCRC receiving first line
      palliative treatment used psychosocial services during this prospective
      longitudinal CRT. Sociodemographic factors (age, education), clinical factors
      (pain and no progressive disease) and the expressed need to talk to a
      professional predicted use of psychosocial services. Identification of these
      predictors may contribute to the understanding of factors that determine the need
      for psychosocial services. TRIAL REGISTRATION: Netherlands Trial Register NTR4034
      .
FAU - Schuurhuizen, Claudia S E W
AU  - Schuurhuizen CSEW
AD  - Department of Medical Oncology, VU University medical center, Cancer Center
      Amsterdam, Amsterdam, the Netherlands.
AD  - Department of Psychiatry and Amsterdam Public Health research institute, VU
      University Medical Center, Amsterdam, the Netherlands.
FAU - Braamse, Annemarie M J
AU  - Braamse AMJ
AD  - Department of Medical Psychology and Amsterdam Public Health Institute, Academic 
      Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
FAU - Konings, Inge R H M
AU  - Konings IRHM
AD  - Department of Medical Oncology, VU University medical center, Cancer Center
      Amsterdam, Amsterdam, the Netherlands.
FAU - Verheul, Henk M W
AU  - Verheul HMW
AD  - Department of Medical Oncology, VU University medical center, Cancer Center
      Amsterdam, Amsterdam, the Netherlands.
FAU - Dekker, Joost
AU  - Dekker J
AD  - Department of Psychiatry and Amsterdam Public Health research institute, VU
      University Medical Center, Amsterdam, the Netherlands. j.dekker@vumc.nl.
LA  - eng
GR  - VU 2011-5279/KWF Kankerbestrijding
PT  - Journal Article
DEP - 20190201
PL  - England
TA  - BMC Cancer
JT  - BMC cancer
JID - 100967800
PMC - PMC6359772
OTO - NOTNLM
OT  - Metastatic colorectal cancer
OT  - Palliative treatment
OT  - Predictors
OT  - Psychosocial services
EDAT- 2019/02/03 06:00
MHDA- 2019/02/03 06:00
CRDT- 2019/02/03 06:00
PHST- 2018/10/02 00:00 [received]
PHST- 2019/01/24 00:00 [accepted]
PHST- 2019/02/03 06:00 [entrez]
PHST- 2019/02/03 06:00 [pubmed]
PHST- 2019/02/03 06:00 [medline]
AID - 10.1186/s12885-019-5318-9 [doi]
AID - 10.1186/s12885-019-5318-9 [pii]
PST - epublish
SO  - BMC Cancer. 2019 Feb 1;19(1):115. doi: 10.1186/s12885-019-5318-9.